Meta facebook tracking pixel

Upcoming Workshops

There are no upcoming workshops

Past workshops

For All Cancers

    1. Understanding Diagnostic Technologies and Biomarkers
    2. Clinical Trials: How They Transform the Treatment of Cancer
    3. Understanding Diagnostic Technologies and Biomarkers
    4. Chemotherapy Treatment Side Effects: Prevention & Management
    5. Clinical Trials: How They Transform the Treatment of Cancer
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer

For Acute Lymphoblastic Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR T-Cell Therapies

For Acute Myeloid Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Update on CAR T-Cell Therapies

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatesPart I of Living with Bladder Cancer
    2. Bladder Cancer: Treatment Updates
    3. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer

For Bone Cancer

    1. Diverse Populations Living with Multiple Myeloma: Treatment Advances
    2. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma

For Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. Metastatic Breast Cancer: Treatment Updates
    3. What’s New in Precision Medicine
    4. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    5. Lobular Breast Cancer: Treatment Progress
    6. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    7. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    8. Metastatic Breast Cancer: Treatment Updates
    9. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    10. The Role of Radiation Therapy in the Treatment of Breast Cancer

For Chronic Lymphocytic Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. What’s New in Precision Medicine
    4. Update on CAR T-Cell Therapies

For Chronic Myelogenous Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. What’s New in Precision Medicine
    4. Update on CAR T-Cell Therapies

For Colorectal Cancer

    1. What’s New in Precision Medicine
    2. Advances in the Treatment of Colorectal Cancer
    3. Colorectal Cancer Treatment: Progress and Advances

For Cutaneous T-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Diffuse Large B-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Endometrial Cancer

    1. Progress in the Treatment of Endometrial Cancer
    2. Progress in the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. Update on CAR T-Cell Therapies
    5. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    6. Non-Hodgkin Lymphoma: Current Treatment Progress
    7. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances

For Head and Neck Cancer

    1. Oral, Head and Neck Cancer: Treatment Updates
    2. Oral, Head & Neck Cancer: Treatment Update

For Hodgkin Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Leukemia

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. What’s New in Precision Medicine
    4. Update on CAR T-Cell Therapies

For Liver Cancer

    1. Liver Cancer: Treatment Update
    2. Liver Cancer: Treatment Updates

For Lung Cancer

    1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    2. Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
    3. What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
    4. Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
    5. Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer

For Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Mantle Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Marginal Zone Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Melanoma

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
    2. Mesothelioma: Innovative Treatment Options

For Metastatic Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. Metastatic Breast Cancer: Treatment Updates
    3. What’s New in Precision Medicine
    4. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    5. Lobular Breast Cancer: Treatment Progress
    6. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    7. Metastatic Breast Cancer: Treatment Updates
    8. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    9. The Role of Radiation Therapy in the Treatment of Breast Cancer

For Multiple Myeloma

    1. Diverse Populations Living with Multiple Myeloma: Treatment Advances
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
    4. Progress in the Treatment of Multiple Myeloma

For Myeloproliferative Neoplasms

    1. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting

For Non-Hodgkin Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Ovarian Cancer

    1. Update on the Treatment of Ovarian Cancer
    2. Ovarian Cancer: Treatment Updates

For Peripheral T-Cell Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Prostate Cancer

    1. Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
    2. Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer

For Skin Cancer

    1. Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma

For Small Lymphocytic Lymphoma

    1. CAR T-Cell Therapy: What’s New
    2. Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
    3. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    4. What’s New in Precision Medicine
    5. Update on CAR T-Cell Therapies
    6. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    7. Non-Hodgkin Lymphoma: Current Treatment Progress
    8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

For Stomach Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Gastric Cancer: Treatment Advances
    3. Gastric Cancer: Treatment Advances
    4. Gastric Cancer: Treatment Advances

For Thyroid Cancer

For Triple Negative Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. Metastatic Breast Cancer: Treatment Updates
    3. What’s New in Precision Medicine
    4. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    5. Lobular Breast Cancer: Treatment Progress
    6. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    7. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    8. Metastatic Breast Cancer: Treatment Updates
    9. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    10. The Role of Radiation Therapy in the Treatment of Breast Cancer

For Uterine Cancer

    1. Progress in the Treatment of Endometrial Cancer
    2. Progress in the Treatment of Endometrial Cancer

For Waldenstrom’s Macroglobulinemia

    1. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.